Sildenafil increases diclofenac antinociception in the formalin test (Q43601463)

25 November 2017

title

Sildenafil increases diclofenac antinociception in the formalin test (English)

1 reference

25 November 2017

1 reference

Asomoza-Espinosa R

1

1 reference

25 November 2017

Alonso-López R

2

1 reference

25 November 2017

Mixcoatl-Zecuatl T

3

1 reference

25 November 2017

Aguirre-Bañuelos P

4

1 reference

25 November 2017

Torres-López JE

5

1 reference

25 November 2017

Granados-Soto V

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

European Journal of Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

418

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

195-200

1 reference

Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive action of meloxicam in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Effect of coadministration of caffeine and either adenosine agonists or cyclic nucleotides on ketorolac analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Sildenafil, a novel effective oral therapy for male erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Ethical guidelines for investigations of experimental pain in conscious animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Evidence for the participation of the nitric oxide-cyclic GMP pathway in the antinociceptive effect of nimesulide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Sildenafil produces antinociception and increases morphine antinociception in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

7 January 2021

cGMP signal termination

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Characterization of the potentiation of the antinociceptive effect of diclofenac by vitamin B complex in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Pharmacology of diclofenac sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Comparative analgesic efficacy of nimesulide and diclofenac gels after topical application on the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Experimental pain induced by electrical and thermal stimulation of the skin in healthy man: sensitivity to 75 and 150 mg diclofenac sodium in comparison with 60 mg codeine and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

Pharmacological Properties of Diclofenac Sodium and Its Metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900956-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)00956-6

1 reference

25 November 2017

1 reference